XII International symposium. Artificial intelligence in diagnosis and monitoring

About symposium

Dear colleagues, we invite you to take part in the International Webinar: «Controversies in glaucoma: artificial intelligence (AI) in diagnosis and monitoring», which will be held on November 10, 2023.

The use of AI in medicine is the most intriguing, full of contradictions, but at the same time extremely promising. It opens up the possibilities of personalized treatment. This fully applies to the use of AI in glaucoma.

Download the program (PDF)

Reports

Welcoming speech and introductions

Cheng Ching Yu

Singapore

AI for all eyes: is glaucoma screening now feasible?

Benjamin Yi Xing Xu

USA

Using AI in Glaucoma Imaging

Fei Li

China

Glaucoma AI: Challenges and Opportunities.

Natalia I. Kurysheva

Russia

The deep learning in the development of the personalized treatment of PAC.

Xiulan Zhang

China

Advances of Artificial Intelligence in Glaucoma Management.

Alexey Antonov

Russia

What is a role of tonometry in the area of AI?

Anna Movsisyan

Moscow, Russian Federation

The possibilities of diagnosing the early stage of glaucoma using an artificial neural network.

Leopold Schmetterer

Austria-Singapore

Big Thinking with Big Data.

Discussion, part 1

Discussion, part 2

Russia

Conclusion

Reporter

Cheng Ching Yu

Singapore

Professor of Department of Ophthalmology of Yong Loo Lin School of Medicine, National University of Singapore. Scientific Faculty Member of SingHealth Duke-NUS Global Health Institute. Professor Cheng’s primary research interests are related to the epidemiology and genetics of major eye diseases. His current work involves in a variety of epidemiological, clinical, and image research on glaucoma. He directs the Singapore Epidemiology of Eye Diseases (SEED) Program, a large multi-disciplinary research program focusing on epidemiology, imaging and genetics on eye diseases in Singapore. Professor Cheng is on the editorial board of several international journals, including Scientific Reports, British Journal of Ophthalmology, Clinical and Experimental Ophthalmology, Translational Vision Science and Technology, and Ophthalmic Epidemiology. He has received a number of prestigious awards, including Clinician Scientist Award (CSA) from National Medical Research Council, Singapore in 2012 and 2017, the Asia-Pacific Academy of Ophthalmology (APAO) Achievement Award, APAO Outstanding Service in Prevention of Blindness Award, and American Academy of Ophthalmology (AAO) Achievement Award.

Benjamin Yi Xing Xu

USA

Assistant Professor Of Clinical Ophthalmology, Director of Inpatient Ophthalmology Service of Keck Hospital of USC. Dr. Xu’s primary research interest is preventing vision loss and blindness in patients at risk for angle closure glaucoma (ACG), a common type of glaucoma. His research focuses on studying the pathophysiology of ACG and improving the care of angle closure patients. Dr. Xu also uses advanced anterior segment imaging modalities including anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM) to study the physiological and biomechanical properties of intraocular structures and aqueous outflow pathways. Finally, Dr. Xu works on designing biomedical devices to assess the function of anterior segment structures, such as the iris and trabecular meshwork. Dr. Xu has coauthored more than 30 peer-reviewed publications and a book on ocular imaging in glaucoma. He has also received numerous research awards, including those from the National Institutes of Health, American Glaucoma Society and Fight for Sight.

Fei Li

China

Dr. Fei Li presently holds the position of assistant professor at Zhongshan Ophthalmic Center, Sun Yat-sen University, and specializes in glaucoma. His research is primarily concentrated on the mechanisms and treatment of glaucoma. As the co-founder of the iChallenge datasets and the lead researcher of the iGlaucoma project, Dr. Li's work extends beyond AI projects to include supervision of research endeavors focused on glaucoma gene therapy and the exploration of neural circuits in glaucoma development. He has been invited to speak at various ophthalmic conferences, such as APAO, APGC, WGC, and AACGC.

Natalia I. Kurysheva

Russia

Dr. of Medical Sciences, Head of the Department of Eye Diseases of the Federal Medical and Biological University of Innovations and Continuing Education of the FMBA of Russia; Professor of the Department of Ophthalmology of the APO of the FSBI FNCC of the FMBA of Russia; Head of the Consultative and Diagnostic Department of the Center of Ophthalmology of the FMBA of Russia; a member of the European Glaucoma Society and the American Academy of Ophthalmology; honorary member of the Italian Glaucoma Society; scientific supervisor and coordinator of the Federal Target Group Programs «Glaucoma Opticoneuropathy». Natalia is a representative of Russian Ophthalmology in the European Association of Predictive, Preventive and Personalized Medicine. The research interests: etiology, pathogenesis, laser and surgical treatment of glaucoma, neuroprotection, angle-closure, normotensive and pseudoexfoliative glaucoma, retinal diseases. For the last 10 years, she has been studying new methods of optic nerve and retina visualization in glaucoma, the progression of the disease, and ocular blood flow and the personalized treatment of the primary angle clouser. Author of more than 300 scientific papers, including 50 papers in international peer-reviewed journals, 10 monographs on the diagnosis and treatment of glaucoma and ocular blood flow, as well as 10 patents for inventions. Member of the editorial board of the National Journal of Glaucoma (Russia) and Ophthalmology Journal (Russia), a reviewer of the British Journal of Ophthalmology (BJO), Bulletin of Ophthalmology and other prominent international journals. She was awarded by the Ministry of Education of the Russian Federation for scientific research on topical issues of fundamental and applied science in the field of education, achievements in the training of highly qualified specialists, for the introduction of new forms and methods of teaching in the educational process. The author of two recent monographs: COVID-19 and visual organ damage, 2021, and Dry age-related macular degenerations, 2021, a member of International Optical Circulation Society (IOCS).

Xiulan Zhang

China

<ul><li>Professor of Ophthalmology at Zhongshan Ophthalmic Center (ZOC) ,China</li><li>TOP 100 most influential people in ophthalmology in the Ophthalmologist Power List (2023, 2014)</li><li>TOP 100 most influential people in ophthalmology in the Asia-Pacific region (2023)</li><li>Top 50 Expertise in Glaucoma Worldwide in Expertscape (2020-2023)</li><li>Fellow of the Academy of Asia-Pacific Professor of Ophthalmology (AAPPO)</li><li>Board member of the Asia-Pacific Glaucoma Society (APGS), the Asia-Pacific Ocular Imaging Society (APOIS) and International AI in Ophthalmology Society (IAIOph)</li><li>Convener of the Glaucoma Scientific Program of Asia-Pacific Academy of Ophthalmology (APAO 2024 , 2019 and2018)</li><li>The Distinguished Service Award of APAO 2021, the Achievement Award of APAO in 2017 </li><li>The Prestigious Achievement Award of Ophthalmic Image Analysis in 2019</li><li>Published 185 SCI articles, Cite Index 5860（Google), H Index 44 (Google Scholar)</li><li>Published four self-authored books<ul class="sub"><li>Illustrated Surgical Techniques and Pearls of MIGS (2022)</li><li>Illustrated anterior segment examinations and diagnosis of glaucoma(2020)</li><li>Illustrated surgical techniques and pearls of glaucoma(2016)</li><li>Illustrated clinical diagnosis and treatment of glaucoma(2014)</li></ul></li><li>Published ten books of translated versions of The WGA Consensus Series and The Asia-Pacific Glaucoma Guideline</ul>

Alexey Antonov

Russia

Leading Researcher, Ph.D. FGBNU «NIIGB named after M.M. Krasnov«. Member of the Expert Council on Glaucoma of the All-Russian Public Organization «Association of Ophthalmologists»; Member of the European Glaucoma Society (European Glaucoma Society); Deputy editor-in- chief of the scientific and clinical publication «National Journal of Glaucoma». His research focuses the biomechanical properties of the cornea and sclera, methods for studying intraocular pressure, diagnosis and treatment of glaucoma. Author of 95 scientific papers, including (as an author and co-author): «Ophthalmotonometry» (2009); «Static perimetry in the diagnosis and monitoring of glaucoma» (2016); 15 patents for the invention. GCP certificate, participation in 6 clinical trials (Phase III) as a co-investigator.

Anna Movsisyan

Moscow, Russian Federation

Assistant at the Department of Ophthalmology Pirogov Russian National Research Medical University. For the highest achievements in studies, special achievements in the scientific and social life of the University, she was awarded the medal «To the Successful», included in the «Golden Register of Graduates of the Moscow State Medical University by I.M. Sechenov - 2016». Winner in 2017 and 2018 among young scientists in the Ophthalmology section at the XII International (XXI All-Russian) and XIII International (XXII All-Russian) Pirogov Scientific Medical Conference of Students and Young Scientists. She was awarded a 3rd degree diploma for her presentation on «The use of neural networks and artificial intelligence as a modern method for diagnosing glaucoma» at the Conference of Young Scientists as part of the «XII Congress of the Russian Society of Ophthalmologists» (2020). Since 2021, she has been a member of the team of the Scientific Vanguard club of young ophthalmologists. Author of 15 published works, including in publications indexed in Scopus, co-author of the book «Primary open-angle glaucoma: a national guide» (2023).

Leopold Schmetterer

Austria-Singapore

Scientific Director and Head of the Eye Visualization Department of the Singapore Eye Research Institute. Professor, Department of Biomedical Engineering, Nanyang Technological University; Honorary Professor of Ophthalmology, Li Kong Chian Medical School, Nanyang Technological University; Visiting Professor, Institute of Ophthalmology, Basel, Switzerland. Professor Schmetterer is involved in many studies of the retina, cornea, glaucoma, and dry eye. He has more than 300 peer-reviewed publications; has been invited to more than 200 lectures; and has received a research funding grant worth more than 35 million Singapore dollars. He is a member of the editorial boards of 10 journals, including Progress in Retinal and Eye Research, Scientific Reports, Acta Ophthalmologica, Journal of Ocular Pharmacology and Therapeutics, Current Eye Research and others, as well as a special reviewer in more than 40 journals.

Program

November 10, 2023

12.00 – 12.05

Welcoming speech and introductions (Greeting: akad. V.A.Chereshnev, professor B. E. Malyugin, professor V.N. Trubilin)

12.05 – 12.20

AI for all eyes: is glaucoma screening now feasible?

Cheng Ching Yu, Singapore

12.05 – 12.20

12.20 – 12.40

Using AI in Glaucoma Imaging

BY Xu, USA

12.20 – 12.40

12.40 – 13.00

Glaucoma AI: Challenges and Opportunities.

Fei Li, China

12.40 – 13.00

13.00– 13.20

The deep learning in the development of the personalized treatment of PAC.

Kurysheva N., Russia

13.00– 13.20

13.20 – 13.40

Advances of Artificial Intelligence in Glaucoma Management.

Zhang X., China

13.20 – 13.40

13.40– 14.00

What is a role of tonometry in the area of AI?

Antonov A., Russia

13.40– 14.00

14.00– 14.20

The possibilities of diagnosing the early stage of glaucoma using an artificial neural network.

Movsisyan A.B., Moscow, Russian Federation

14.00– 14.20

14.20– 14.40

Big Thinking with Big Data.

Shmetterer L., Austria-Singapore

14.20– 14.40

XII International symposium
Artificial intelligence in diagnosis and monitoring

About symposium

Reports

Reporter

Program

Welcoming speech and introductions (Greeting: akad. V.A.Chereshnev, professor B. E. Malyugin, professor V.N. Trubilin)

AI for all eyes: is glaucoma screening now feasible?

Using AI in Glaucoma Imaging

Glaucoma AI: Challenges and Opportunities.

The deep learning in the development of the personalized treatment of PAC.

Advances of Artificial Intelligence in Glaucoma Management.

What is a role of tonometry in the area of AI?

The possibilities of diagnosing the early stage of glaucoma using an artificial neural network.

Big Thinking with Big Data.

Sponsors

Organizers

Information partners